JONATHAN D. ADAMS, PHARM, D.; JAMES P. WILSON, PHARM, D.
This content is PDF only. Please click on the PDF icon to access.
To the editors: in the letter from pandya and chang (1) the dose of dactinomycin was given as 10 mg/m2 body surface area. It appears that this dose is in error. An article (2) cited by Pandya and Chang reported an Einhorn-type regimen and did not use dactinomycin. Most VAB (vinblastine, dactinomycin, and bleomycin) regimens (3-5), as the authors' appears to be, use a dactinomycin dose of 1 mg/m2 body surface area. We suggest that a decimal point is missing, and that anyone interested in using the authors' regimen carefully review this dose.
ADAMS JD, WILSON JP. Correction: Dactinomycin Dose. Ann Intern Med. ;98:262–263. doi: 10.7326/0003-4819-98-2-262_3
Download citation file:
© 2019
Published: Ann Intern Med. 1983;98(2):262-263.
DOI: 10.7326/0003-4819-98-2-262_3